Comparison of D-G3139 and Its Enantiomer L-G3139 in Melanoma Cells Demonstrates Minimal In Vitro but Dramatic In Vivo Chiral Dependency-Reference-Cited by-同舟云学术

Comparison of D-G3139 and Its Enantiomer L-G3139 in Melanoma Cells Demonstrates Minimal In Vitro but Dramatic In Vivo Chiral Dependency

Published:2007-02 Issue:2 Volume:15 Page:270-278
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Lai Johnathan C,Brown Bob D,Voskresenskiy Anatoliy M,Vonhoff Stefan,Klussman Sven,Tan Wenzhi,Colombini Marco,Weeratna Risini,Miller Paul,Benimetskaya Luba,Stein Cy A

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi;Saenz-Santamaria;J Cutan Pathol,1994

2. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture;Plettenberg;Am J Pathol,1995

3. bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi;Cerroni;Am J Dermatopathol,1995

4. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line;Miyashita;Blood,1993

5. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair;Kamesaki;Cancer Res,1993

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bozepinib: A Promising Selective Derivative Targeting Breast Cancer Stem Cells;Translational Research in Cancer;2021-02-03

2. Electronic Structures of LNA Phosphorothioate Oligonucleotides;Molecular Therapy - Nucleic Acids;2017-09

3. Quantum Mechanical Studies of DNA and LNA;Nucleic Acid Therapeutics;2014-04

4. VDAC blockage by phosphorothioate oligonucleotides and its implication in apoptosis;Biochimica et Biophysica Acta (BBA) - Biomembranes;2012-06

5. New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine;European Journal of Medicinal Chemistry;2011-01